Justin Penn1, Ilan Goldenberg2, Scott McNitt3, Bronislava Polonsky3, Martin H Ruwald3, Wojciech Zareba3, Arthur J Moss3, Jeffrey D Alexis4. 1. Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado. 2. Heart Research Follow-up Program, Division of Cardiology, University of Rochester School of Medicine and Dentistry, Rochester, New York; Sheba Medical Center and Tel Aviv University, Tel Aviv, Israel. 3. Heart Research Follow-up Program, Division of Cardiology, University of Rochester School of Medicine and Dentistry, Rochester, New York. 4. Heart Research Follow-up Program, Division of Cardiology, University of Rochester School of Medicine and Dentistry, Rochester, New York. Electronic address: Jeffrey_alexis@urmc.rochester.edu.
Abstract
BACKGROUND: This study sought to assess the association between medication utilization, outcome, and the efficacy of resynchronization therapy in the MADIT-CRT study. METHODS AND RESULTS: Medication use by patients in the MADIT-CRT study was analyzed. Time-dependent Cox proportional hazard regression analyses were performed to assess differences in hospitalization for heart failure (HF) or death. The greater the efficacy of cardiac resynchronization therapy (CRT) as measured by reduction in left ventricular end-systolic volume (LVESV) and increase in left ventricular ejection fraction (LVEF) between baseline and 1 year of follow-up, the greater the likelihood that patients remained on an angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB) and avoided use of or reduced treatment with diuretics. Treatment with diuretics was associated with a significantly increased risk of HF hospitalization or death (hazard ratio [HR] 1.87, 95% confidence interval [CI] 1.45-2.41; P < .001). In contrast, treatment with an ACE-I/ARB was associated with a significantly decreased risk of HF hospitalization or death (HR 0.58, 95% CI 0.42-0.80; P = .001). CONCLUSIONS: In HF patients in New York Heart Associationfunctional classes I and II and with wide QRS complexes, efficacy of CRT as measured by improvement in LVESV and LVEF was associated with an increased likelihood of remaining on an ACE-I/ARB and discontinuing diuretic therapy. Discontinuation of diuretics was reflective of improved hemodynamic response to CRT.
RCT Entities:
BACKGROUND: This study sought to assess the association between medication utilization, outcome, and the efficacy of resynchronization therapy in the MADIT-CRT study. METHODS AND RESULTS: Medication use by patients in the MADIT-CRT study was analyzed. Time-dependent Cox proportional hazard regression analyses were performed to assess differences in hospitalization for heart failure (HF) or death. The greater the efficacy of cardiac resynchronization therapy (CRT) as measured by reduction in left ventricular end-systolic volume (LVESV) and increase in left ventricular ejection fraction (LVEF) between baseline and 1 year of follow-up, the greater the likelihood that patients remained on an angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB) and avoided use of or reduced treatment with diuretics. Treatment with diuretics was associated with a significantly increased risk of HF hospitalization or death (hazard ratio [HR] 1.87, 95% confidence interval [CI] 1.45-2.41; P < .001). In contrast, treatment with an ACE-I/ARB was associated with a significantly decreased risk of HF hospitalization or death (HR 0.58, 95% CI 0.42-0.80; P = .001). CONCLUSIONS: In HF patients in New York Heart Association functional classes I and II and with wide QRS complexes, efficacy of CRT as measured by improvement in LVESV and LVEF was associated with an increased likelihood of remaining on an ACE-I/ARB and discontinuing diuretic therapy. Discontinuation of diuretics was reflective of improved hemodynamic response to CRT.
Authors: Brian Kerr; Rebabonye B Pharithi; Matthew Barrett; Carmel Halley; Joe Gallagher; Mark Ledwidge; Kenneth McDonald Journal: Int J Heart Fail Date: 2021-02-25
Authors: Belén Alvarez-Alvarez; Javier García-Seara; Jose L Martínez-Sande; Moisés Rodríguez-Mañero; Xesús A Fernández López; Laila González-Melchor; Rosa M Agra Bermejo; Diego Iglesias-Alvarez; Francisco Gude Sampedro; Carla Díaz-Louzao; José R González-Juanatey Journal: J Arrhythm Date: 2018-08-07
Authors: Samaneh Salimian; Marc W Deyell; Jason G Andrade; Santabhanu Chakrabarti; Matthew T Bennett; Andrew D Krahn; Nathaniel M Hawkins Journal: Heart Rhythm O2 Date: 2021-12-17
Authors: Elif Kaya; Jochen Senges; Matthias Hochadel; Lars Eckardt; Dietrich Andresen; Hüseyin Ince; Stefan G Spitzer; Thomas Kleemann; Sebastian S K Maier; Werner Jung; Christoph Stellbrink; Tienush Rassaf; Reza Wakili Journal: ESC Heart Fail Date: 2020-02-18